Desarrollo E Investigacion Medica Aragonesa SL FDA Record
- Latest inspection OAI · Dec 19, 2019
- Last warning letter 2014
Desarrollo E Investigacion Medica Aragonesa SL has 0 FDA recalls, 3 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Desarrollo E Investigacion Medica Aragonesa SL, the most recent on Oct 15, 2014.
- Latest inspection
- Dec 19, 2019 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 3 | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Desarrollo E Investigacion Medica Aragonesa SL as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Desarrollo E Investigacion Medica Aragonesa SL yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Desarrollo E Investigacion Medica Aragonesa SL FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Oct 15, 2014 · Record page |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Dec 19, 2019 | Calatayud, Spain | Devices | Official Action Indicated (OAI) | 3006621295 |
| Jan 27, 2016 | Calatayud, Spain | Devices | No Action Indicated (NAI) | 3006621295 |
| Jul 3, 2014 | Calatayud, Spain | Devices | No Action Indicated (NAI) | 3006621295 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Desarrollo E Investigacion Medica Aragonesa SL: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3006621295 | Calatayud, Spain | 3 | Dec 19, 2019 |
Desarrollo E Investigacion Medica Aragonesa SL and the FDA: common questions
Has Desarrollo E Investigacion Medica Aragonesa SL received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Desarrollo E Investigacion Medica Aragonesa SL. The most recent is dated Oct 15, 2014.
Has Desarrollo E Investigacion Medica Aragonesa SL received an FDA Form 483?
FDA has not published a Form 483 for "Desarrollo E Investigacion Medica Aragonesa SL" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Desarrollo E Investigacion Medica Aragonesa SL?
The most recent FDA inspection on file ended Dec 19, 2019 at Calatayud, Spain and was classified OAI. FDA has 3 inspections of Desarrollo E Investigacion Medica Aragonesa SL on file, 1 of them classified OAI (official action indicated).
Need more than this page shows? Ask about Desarrollo E Investigacion Medica Aragonesa SL in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.